Webster Pharmacy Semaglutide Review

Webster Pharmacy is a genuine independent community pharmacy — a different proposition from the national telehealth platforms and large-scale compounders elsewhere in this comparison. Our research (August 8, 2026) found a verifiable local business promoting a formulation whose evidence base does not exist.

It Is a Real Place

Webster describes itself as "a functional and compounding pharmacy in Webster Groves, Missouri," operating from 608 Lockwood Ave, Webster Groves, MO 63119 with regular store hours and a mobile app for managing refills. That matters and it is worth saying first. Across this category we have repeatedly flagged providers that will not name their compounding pharmacy, will not state a location, and cannot be visited. Webster has an address you can walk into and a pharmacist you can speak to face to face. For anyone who wants a compounded medication and a human being accountable for it in the same building, that is a real advantage.

The Sublingual Semaglutide Problem

Webster prominently features sublingual semaglutide, promoted with the message "Injection not required." The appeal is obvious and the evidence is not there. Two things a buyer should understand: The approved oral semaglutide is a specific, engineered formulation. Rybelsus achieves oral absorption using an absorption enhancer (SNAC) that protects the peptide from stomach acid and helps it cross the gastric lining. That formulation was developed and trialled precisely because semaglutide is a large peptide that is otherwise destroyed or poorly absorbed by the oral route. A compounded sublingual preparation is not Rybelsus and does not share its absorption technology. Compounded sublingual semaglutide has not been through the trials. The STEP programme that established semaglutide's efficacy used the injectable, and Rybelsus has its own approval trials. Neither body of evidence transfers to a compounded sublingual drop or troche. As our head-to-head comparison notes, the trial results everyone quotes were generated with specific approved products. We are not asserting that a sublingual preparation does nothing. We are stating that no published trial evidence establishes what dose reaches your bloodstream from a compounded sublingual formulation, and that "injection not required" is a convenience claim rather than an efficacy one. Our reviews of other providers offering oral GLP-1 formulations have noted the same pattern: independent reviewers consistently report weaker results from oral than injectable compounded products.

What Is Not Disclosed

No 503A or 503B status. As with Vios, the single most important regulatory fact about a compounding pharmacy is absent. Strive publishes its 503A status alongside PCAB, NABP and LegitScript accreditation; Webster publishes neither pathway nor accreditations. No shipping reach, pricing or refund terms were stated in the material we reviewed.